Researchers Find Tumor-Based Methylation Patterns as Cancer Biomarkers
Researchers identified cancer biomarkers based on a type of genetic modification that predicts the type of tumor immune environment and patient outcomes.
Researchers identified cancer biomarkers based on a type of genetic modification that predicts the type of tumor immune environment and patient outcomes.
It’s graduation season around the country with new graduates ready to commence with their careers. But where are the new laboratorians?
Laboratory leadership needs to develop coherent succession planning to allow for the continuity of laboratory operations.
Researchers identified cancer biomarkers based on a type of genetic modification that predicts the type of tumor immune environment and patient outcomes.
Tethis S.p.A released a universal blood sample preparator for liquid biopsies, which performs automated blood sample preparation.
The system automates tasks such as serial dilutions, sample normalization, hit picking or pipetting of complex plate layouts.
The Center of BioModular Multi-Scale Systems for Precision Medicine creates rapid tests for human ailments like cancer, stroke, and COVID.
The biomarkers can predict a patient’s response to immunotherapy and the adverse events they may experience from the same immunotherapy.
Molecular Devices launched its SpectraMax Mini Multi-Mode Microplate Reader, aimed to save researchers benchtop space and budget.
Verichem Laboratories now offers completely liquid stable clinical reference materials for both total and direct Bilirubin assays.
Freenome completed the enrollment for PREEMPT CRC, a large, prospective study to validate its blood test for colorectal cancer screening.
Avista Capital Partners, a private equity firm focused on healthcare, closed on the sale of pathology laboratory Inform Diagnostics to Fulgent Genetics.
Researchers have developed a smart diaper that measures multiple components in urine and can share those results over Bluetooth.